Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autoimmunity: regulatory B cells--IL-35 and IL-21 regulate the regulators.

Literature DB >> 24934192

Autoimmunity: regulatory B cells--IL-35 and IL-21 regulate the regulators.

Abstract

IL-21 regulates the activity and number of IL-10-producing regulatory B cells (B10 cells) that modulate immune responses and limit diverse autoimmune diseases. A new study demonstrates that IL-35 has a similar function. Identifying regulatory circuits that control B10-cell function in vivo might open the door to future treatments for autoimmune diseases.

Entities: Disease Gene

Mesh：

Substances：

Year: 2014 PMID： 24934192 DOI： 10.1038/nrrheum.2014.95

Source DB: PubMed Journal: Nat Rev Rheumatol ISSN： 1759-4790 Impact factor: 20.543

10 in total

1. The composition and signaling of the IL-35 receptor are unconventional.

Authors: Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal: Nat Immunol Date: 2012-02-05 Impact factor: 25.606

Review 2. Interleukin-21: a double-edged sword with therapeutic potential.

Authors: Rosanne Spolski; Warren J Leonard
Journal: Nat Rev Drug Discov Date: 2014-04-22 Impact factor: 84.694

Review 3. IL-12 family cytokines: immunological playmakers.

Authors: Dario A A Vignali; Vijay K Kuchroo
Journal: Nat Immunol Date: 2012-07-19 Impact factor: 25.606

4. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors: Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal: Nature Date: 2007-11-22 Impact factor: 49.962

Review 5. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.

Authors: Jacques Banchereau; Virginia Pascual; Anne O'Garra
Journal: Nat Immunol Date: 2012-09-18 Impact factor: 25.606

6. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells.

Authors: Wanda Niedbala; Xiao-Qing Wei; Beilei Cai; Axel J Hueber; Bernard P Leung; Iain B McInnes; Foo Y Liew
Journal: Eur J Immunol Date: 2007-11 Impact factor: 5.532

7. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.

Authors: Ping Shen; Toralf Roch; Vicky Lampropoulou; Richard A O'Connor; Ulrik Stervbo; Ellen Hilgenberg; Stefanie Ries; Van Duc Dang; Yarúa Jaimes; Capucine Daridon; Rui Li; Luc Jouneau; Pierre Boudinot; Siska Wilantri; Imme Sakwa; Yusei Miyazaki; Melanie D Leech; Rhoanne C McPherson; Stefan Wirtz; Markus Neurath; Kai Hoehlig; Edgar Meinl; Andreas Grützkau; Joachim R Grün; Katharina Horn; Anja A Kühl; Thomas Dörner; Amit Bar-Or; Stefan H E Kaufmann; Stephen M Anderton; Simon Fillatreau
Journal: Nature Date: 2014-02-23 Impact factor: 49.962

8. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.

Authors: Ayumi Yoshizaki; Tomomitsu Miyagaki; David J DiLillo; Takashi Matsushita; Mayuka Horikawa; Evgueni I Kountikov; Rosanne Spolski; Jonathan C Poe; Warren J Leonard; Thomas F Tedder
Journal: Nature Date: 2012-10-14 Impact factor: 49.962

Review 9. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease.

Authors: Ioannis Kalampokis; Ayumi Yoshizaki; Thomas F Tedder
Journal: Arthritis Res Ther Date: 2013-02-11 Impact factor: 5.156

10. Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Authors: Ren-Xi Wang; Cheng-Rong Yu; Ivy M Dambuza; Rashid M Mahdi; Monika B Dolinska; Yuri V Sergeev; Paul T Wingfield; Sung-Hye Kim; Charles E Egwuagu
Journal: Nat Med Date: 2014-04-17 Impact factor: 53.440

10 in total

25 in total

1. CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors: Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal: JCI Insight Date: 2018-12-06

Review 2. Interleukin-35: Expanding Its Job Profile.

Authors: Deepali V Sawant; Kristia Hamilton; Dario A A Vignali
Journal: J Interferon Cytokine Res Date: 2015-04-28 Impact factor: 2.607

Review 3. IL-35 and Autoimmunity: a Comprehensive Perspective.

Authors: Jinjung Choi; Patrick S C Leung; Christopher Bowlus; M Eric Gershwin
Journal: Clin Rev Allergy Immunol Date: 2015-12 Impact factor: 8.667

Review 4. Interleukin 30 to Interleukin 40.

Authors: Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal: J Interferon Cytokine Res Date: 2018-10 Impact factor: 2.607

5. Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance.

Authors: Jeremy A Sullivan; Yusuke Tomita; Ewa Jankowska-Gan; Diego A Lema; Matt P Arvedson; Ashita Nair; William Bracamonte-Baran; Ying Zhou; Kristy K Meyer; Weixiong Zhong; Deepali V Sawant; Andrea L Szymczak-Workman; Qianxia Zhang; Creg J Workman; Seungpyo Hong; Dario A A Vignali; William J Burlingham
Journal: Cell Rep Date: 2020-01-28 Impact factor: 9.423

6. B10 Cells Are Associated With Clinical Prognosis During Adult Symptomatic Acute HBV Infection.

Authors: Yali Liu; Xiaofei Du; Junfeng Lu; Lina Ma; Yi Jing; Haijing Ben; Xinyue Chen; Jing Zhang
Journal: Front Immunol Date: 2022-06-13 Impact factor: 8.786

7. CD27⁺TIM-1⁺ memory B cells promoted the development of Foxp3⁺ Tregs and were associated with better survival in acute respiratory distress syndrome.

Authors: Guangfa Zhu; Yan Liu; Wenmei Zhang; Yan Huang; Keng Li
Journal: Immunol Res Date: 2018-04 Impact factor: 2.829